Aligos Therapeutics, Inc. (ALGS) has a market capitalization of $52.91M and trades at $8.55. The 52-week range is 3.76-13.689.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.5, Earnings Per Share (EPS) of $-2.45, annual revenue of $2.19M.
The stock has a beta of 2.62, operates in the Healthcare sector.
